左心室辅助装置患者重复测量峰值摄氧量的预后价值
本研究为PRO-VAD研究的随访分析,纳入152例在LVAD植入后约6个月和12个月重复进行心肺运动试验的患者。结果显示,持续高pVO2与死亡风险降低5倍相关,从低到高的改善也显示类似获益,提示重复测量pVO2具有额外预后价值。
要点
- LVAD患者重复测量pVO2可预测死亡风险,持续高pVO2者预后极佳。
- pVO2从低改善至高同样与死亡风险显著降低相关。
- pVO2变化有助于识别需要进一步干预的患者。
核心结论
- 在LVAD患者中,重复测量pVO2仍可预测死亡,且pVO2变化提供额外预后价值。
研究设计与样本
- 多中心随访研究,纳入原PRO-VAD队列中重复进行心肺运动试验的患者,共152例,两次CPET约在LVAD植入后6个月和12个月。
主要发现
- 队列pVO2有轻微但显著改善,中位变化0.4 ml/kg/min,p=0.04。
- 持续高pVO2(76例)与持续低pVO2(46例)相比,死亡风险降低5倍(HR 0.20,p=0.002)。
- 从低到高pVO2(21例)显示类似获益(HR 0.21,p=0.02)。
关键数值与推荐
- 低pVO2定义为≤14 ml/kg/min(或≤12 ml/kg/min若耐受β受体阻滞剂),高于阈值定义为高。
临床怎么用
- 对LVAD患者可考虑重复进行心肺运动试验测量pVO2,以动态评估预后并识别需进一步干预者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peak oxygen uptake (pVO2) predicts mortality in patients with heart failure on left ventricular assist device (LVAD) support. This follow-up of the PRO-VAD study examines the prognostic value of repeated pVO2 measurements during long-term follow-up. METHODS: This multicenter follow-up study included patients from the original PRO-VAD cohort who performed a cardiopulmonary exercise test (CPET) twice. Patients were categorized into 4 groups based on pVO2 levels at the 2 CPETs: low at both tests, low at the first and high at the second test, high at the first and low at the second test, and high at both tests. Low pVO2 was defined as ≤14 ml/kg/min (or ≤12 ml/kg/min if beta-blocker tolerant), while values above these thresholds were considered high. Survival outcomes were analyzed using the Kaplan-Meier method and cause-specific Cox analysis. RESULTS: The study included 152 patients with repeated CPETs at approximately 6 and 12 months following LVAD implantation. The cohort showed slight but significant pVO2 improvement (median change: 0.4 ml/kg/min, p = 0.04). Persistently high pVO2 (76 patients) was associated with a 5-fold reduction in mortality hazard (hazard ratio [HR] 0.20, p = 0.002), compared with persistently low pVO2 (46 patients). Improvement from low to high pVO2 (21 patients) displayed similar benefits (HR 0.21, p = 0.02). CONCLUSIONS: pVO2 measurements remain predictive of mortality upon reiteration in patients with LVAD, with changes in pVO2 providing additional prognostic value in identifying patients with an excellent outcome on ongoing LVAD support and in identifying patients requiring further interventions.
引用
- Nielsen WH, Szymanski MK, Mirza KK, et al. Prognostic value of repeated peak oxygen uptake measurements in patients with a left ventricular assist device. J Heart Lung Transplant. 2024. PMID: 39426458. doi:10.1016/j.healun.2024.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。